We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Advisory Panel Splits Over Expanded Indications for Medtronic’s CRT Line
Advisory Panel Splits Over Expanded Indications for Medtronic’s CRT Line
October 11, 2013
A divided Circulatory System Devices Panel grappled with fine distinctions in risk-benefit tradeoffs before voting to expand use of two Medtronic heart failure products to treat patients with atrial ventricular block and reduced heart function.